Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors

Journal of Clinical Oncology

Volumn 25, Issue 35, 2007, Pages 5603-5608

  Carver, Brett S ^a   Serio, Angel M ^a   Bajorin, Dean ^a   Motzer, Robert J ^a   Stasi, Jason ^a   Bosl, George J ^a   Vickers, Andrew J ^a   Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; HUMANS; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 37649004099     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.6283     Document Type: Article

References (22)

1. Carver BS, Sheinfeld J: Germ cell tumors of the testis. Ann Surg Oncol 12:871-880, 2005
2. American Cancer Society: Cancer Facts and Figures 2007. http://www.cancer.org
3. Sheinfeld J, Herr HW: Role of surgery in management of germ cell tumor. Semin Oncol 25:203-209, 1998
4. McKiernan J, Goluboff E, Liberson G, et al: Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162:361-363, 1999
5. Purdue MP, Devesa SS, Sigurdson AJ, et al: International patterns and trends in testis cancer incidence. Int J Cancer 115:822-827, 2005
6. Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al: Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse. J Clin Oncol 19:2020-2025, 2001
7. IGCCCG: International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603, 1997
8. Carver BS, Motzer RJ, Kondagunta GV, et al: Late relapse of testicular germ cell tumors. Urol Oncol 23:441-445, 2005
9. Baniel J, Foster RS, Gonin R, et al: Late relapse of testicular cancer. J Clin Oncol 13:1170-1176, 1995
10. George DW, Foster RS, Hromas RA, et al: Update on late relapse of germ cell tumor: A clinical and molecular analysis. J Clin Oncol 21:113-122, 2003
11. McGlynn KA, Devesa SS, Graubard BI, et al: Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 23:5757-5761, 2005
12. Powles TB, Bhardwa J, Shamash J, et al: The changing presentation of germ cell tumours of the testis between 1983 and 2002. BJU Int 95:1197-1200, 2005
13. Bhardwa JM, Powles T, Berney D, et al: Assessing the size and stage of testicular germ cell tumours: 1984-2003. BJU Int 96:819-821, 2005
14. Vasudev NS, Joffe JK, Cooke C, et al: Delay in the diagnosis of testicular tumours: Changes over the past 18 years. Br J Gen Pract 54:595-597, 2004
15. Stephenson AJ, Bosl GJ, Motzer RJ, et al: Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: Impact of patient selection factors on outcome. J Clin Oncol 23:2781-2788, 2005
16. Bosl GJ, Geller NL, Cirrincione C, et al: Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43:3403-3407, 1983
17. Medical Research Council: Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: Results of a multicentre study - Report from the Medical Research Council Working Party on Testicular Tumours. Lancet 1:8-11, 1985
18. Stoter G, Sylvester R, Sleijfer DT, et al: Multivariate analysis of prognostic variables in patients with disseminated non-seminomatous testicular cancer: Results from an EORTC multi-institutional phase III study. Int J Androl 10:239-246, 1987
19. Bajorin D, Katz A, Chan E, et al: Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies. J Clin Oncol 6:786-792, 1988
20. Hitchins RN, Newlands ES, Smith DB, et al: Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: Comparison of commonly used classification systems of good and poor prognosis. Br J Cancer 59:236-242, 1989
21. McKiernan JM, Motzer RJ, Bajorin DF, et al: Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: Clinical presentation, patterns of recurrence, and outcome. Urology 62:732-736, 2003
22. Muramaki M, Hara I, Miyake H, et al: Clinical outcome of retroperitoneal lymph node dissection after induction chemotherapy for metastatic nonseminomatous germ cell tumors. Int J Urol 11:763-767, 2004